4.75EUR
75.80 MEUR
77.70 MEUR
10.10 M
About FORMYCON AG
Sector
CEO
Stefan Glombitza
Headquarters
Munich
Website
Founded
2007
ISIN
DE000A1EWVY8
FIGI
BBG001BW8W05
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205, which focuses in the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of FYB is 40.20 EUR — it has decreased by 6.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange FORMYCON AG stocks are traded under the ticker FYB.
FORMYCON AG is going to release the next earnings report on Sep 17, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for FORMYCON AG has a max estimate of 101.00 EUR and a min estimate of 89.00 EUR.
Yes, you can track FORMYCON AG financials in yearly and quarterly reports right on TradingView.
Like other stocks, FYB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FORMYCON AG stock right from TradingView charts — choose your broker and connect to your account.